CASRAI Dictionary

Tag: procedure for the investigation of misconduct in research

  • Famous Cases of Research Misconduct in India: Building Investigation Capacity

    India has produced a long run of documented research misconduct cases — plagiarism by university vice-chancellors, data manipulation at premier institutes, and mass retractions from the Indian Institutes of Technology (IITs) — because the country has no statutory equivalent of the US Office of Research Integrity. Since 2018, that gap has started closing through UGC regulations, an ICMR ethics policy, and India’s first dedicated Research Integrity Office, opened in Bengaluru in 2022.

    Research misconduct is the fabrication, falsification, or plagiarism of data or authorship in proposing, performing, or reviewing research, or in reporting research results. In India, the term also commonly extends to duplicate (“self-plagiarism”) publication and fraudulent peer review, both of which feature heavily in the country’s retraction record.

    This article sets out the famous cases of research misconduct in india that shaped public and regulatory attention, then examines — in more depth than the case lists alone provide — the specific institutional mechanisms India has built since 2018 to investigate and deter misconduct, benchmarked against the UK’s comparable framework.

    What is research misconduct, and how common is it in India?

    Research misconduct covers fabrication, falsification, plagiarism, and — in India’s documented record — duplicate publication and compromised peer review. India does not operate a statutory oversight body comparable to the US Office of Research Integrity, so cases are typically investigated on an ad-hoc basis by institutional committees, independent enquiry panels, or journal editors, often only after a public complaint or media report triggers action.

    Retraction volume gives a rough proxy for scale. An analysis by the volunteer watchdog Indian Research Watch (IRW), drawing on the Retraction Watch database, found that 58 papers authored or co-authored by faculty across 12 of India’s 23 IITs were retracted for plagiarism or duplicate publication between 2006 and 2023 — compared with three retractions from Stanford, two from Princeton, five from Oxford, five from Cambridge, and ten from Tsinghua over the same period. IRW also recorded a 2.5-fold surge in Indian institutional retractions in 2020–2022 compared with 2017–2019.

    Which cases shaped India’s research misconduct record?

    A handful of cases became reference points for how India investigates — and fails to investigate — misconduct allegations.

    • B.S. Rajput, Kumaon University (2002–2003): the vice-chancellor was accused by Indian and international physicists, including a Nobel laureate co-signatory, of plagiarising a paper from a Stanford researcher. A committee led by retired judge Justice S.R. Singh upheld the charge in February 2003, and Rajput resigned immediately.
    • Gopal Kundu, National Centre for Cell Science, Pune (2006–2010): an anonymous complaint alleged data misrepresentation in a Journal of Biological Chemistry paper. The journal withdrew the paper in 2007, and the Indian Academy of Sciences barred Kundu from its activities for three years following an internal ethics review in 2010.
    • Ashok Kumar, IIT Kanpur (2010): two review articles in Biotechnology Advances were retracted for extensive copying, prompting the Society for Scientific Values to publicly reprimand several IITs over lax plagiarism handling that year.
    • P. Chiranjeevi, Sri Venkateswara University (2004–2008): a chemistry professor was found to have plagiarised content across roughly 70 papers; the university barred him from examination duties, research guidance, and further promotion.
    • Sanjeeb Kumar Sahoo, Institute of Life Sciences, Bhubaneswar (2013): five papers in Acta Biomaterialia were retracted for serial self-plagiarism, data manipulation, and falsification of results.

    These cases share a pattern: detection came from external whistleblowers, journal editors, or watchdog groups rather than routine institutional audit — the exact gap India’s newer capacity-building measures target.

    How are Indian institutions building investigation capacity?

    Since 2018, national regulators and individual institutions have begun replacing ad-hoc responses with defined procedures, though implementation remains uneven across India’s roughly 1,000-plus universities.

    • UGC (Promotion of Academic Integrity and Prevention of Plagiarism in Higher Educational Institutions) Regulations, 2018: the University Grants Commission’s regulation defines plagiarism thresholds by similarity-index band and prescribes tiered penalties, from reworking a manuscript to debarment from supervising research.
    • Mandatory Research and Publication Ethics (RPE) training: UGC rules require a two-credit RPE course for all PhD scholars, intended to instil ethical practice before misconduct occurs rather than only punishing it afterward.
    • UGC-CARE (Consortium for Academic and Research Ethics): maintains a vetted journal list to steer researchers away from predatory publications that facilitate low-scrutiny misconduct.
    • ICMR research integrity policy: the Indian Council of Medical Research has its own publication-ethics and research-integrity policy governing biomedical research, alongside its National Ethical Guidelines for Biomedical and Health Research.
    • India’s first dedicated Research Integrity Office: in 2022, the Institute for Stem Cell Science and Regenerative Medicine (inStem) and the National Centre for Biological Sciences (NCBS) in Bengaluru jointly established India’s first standing Research Integrity Office, tasked with policy-setting, data archiving, training, and case investigation — a structural model still rare outside this campus.
    • Independent watchdogs: the Society for Scientific Values, active since the 1980s, and Indian Research Watch, founded in 2022 by data scientist Achal Agrawal, continue to supply the external scrutiny that formal bodies have not yet fully absorbed.

    How does India’s framework compare with the UK’s?

    The UK’s research misconduct architecture is older and more codified, offering a useful benchmark for what a mature system looks like once statutory pressure and funder mandates are added.

    Feature India United Kingdom
    Core guidance document UGC 2018 Regulations; ICMR research integrity policy Universities UK Concordat to Support Research Integrity (2019 revision)
    Statutory oversight body None — no equivalent to the US Office of Research Integrity None — UK Research Integrity Office (UKRIO) is advisory, not statutory
    Institutional requirement Ethics/misconduct committees, variably implemented Named research integrity lead plus an annual public statement to funders
    Investigation trigger Usually a whistleblower complaint or media report Defined internal procedure for the investigation of misconduct in research, often COPE-aligned, with escalation routes to funders

    The comparison shows India’s 2018–2022 reforms following a similar path the UK walked earlier — moving from voluntary good practice toward named responsibility and funder-linked reporting — but roughly a decade behind in institutional coverage.

    Frequently asked questions

    What are some examples of research misconduct?

    Fabrication, falsification, and plagiarism are the three core categories recognised internationally. In India’s record, this has manifested as copied text and images, manipulated western blot data, duplicate (“self-plagiarised”) publication, and fraudulent peer review used to fast-track weak manuscripts into print.

    What are the 5 unethical practices in research?

    The five widely cited categories are falsification of data, failure to credit others, plagiarism, conflicts of interest, and biased design or interpretation driven by outside influence. Indian cases documented above illustrate the first three most frequently, particularly plagiarism and data falsification.

    What are the implications for institutions, publishers, and funders?

    For Indian institutions, the direction is toward standing capacity rather than reactive committees: named integrity offices, mandatory ethics training, and journal-quality filtering via UGC-CARE. For international publishers and funders working with Indian co-authors, the retraction data signal a need for stronger pre-publication screening rather than reliance on post-hoc whistleblowing. For research administrators globally, India’s experience underscores a broader lesson also visible in research administration practice elsewhere: investigation procedures only function once an institution has a named owner, a documented process, and independence from the department under review.

    Conclusion: the road ahead

    India’s famous research misconduct cases exposed a structural gap: no statutory body, uneven institutional follow-through, and detection driven mostly by outsiders. The 2018 UGC regulations, ICMR’s integrity policy, mandatory RPE training, and the 2022 inStem/NCBS Research Integrity Office mark a genuine shift toward standing investigation capacity. Whether that capacity scales beyond a handful of leading institutions to India’s broader university system remains the open question for the next decade.

  • Research Misconduct Allegation Phases (3 Stages)

    A research misconduct allegation moves through three formal stages — inquiry, investigation and adjudication — each with a distinct purpose, evidentiary threshold and, under the US federal model, a defined deadline. The inquiry screens whether a full investigation is warranted; the investigation builds a factual record; adjudication delivers the finding and any sanctions. This article walks through each phase in order, then contrasts the US federal timetable with the more variable UK institutional model.

    Research misconduct is formally defined, under the US Public Health Service policy (42 C.F.R. Part 93), as fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results — a definition that explicitly excludes honest error and legitimate differences of scientific opinion.

    What Is a Research Misconduct Allegation?

    A research misconduct allegation is a formal statement, made by a complainant to a designated institutional official — typically a Research Integrity Officer (RIO) — that a named respondent has fabricated, falsified or plagiarised research. The allegation triggers a duty on the institution to make a preliminary assessment before any formal phase begins. This assessment is not itself one of the three formal phases; it simply determines whether the allegation, if true, would fall within the scope of research misconduct.

    Phase One: The Inquiry

    The inquiry is a preliminary, confidential fact-check, not a determination of guilt. Its sole question is whether the allegation has enough substance to warrant a full investigation.

    • A small committee or designated official gathers documents and research records.
    • The respondent and complainant may be interviewed informally.
    • A written inquiry report records the findings and a recommendation on whether to proceed.

    Under 42 C.F.R. §93.307(g), US institutions receiving Public Health Service funding must complete the inquiry within 60 calendar days of initiation unless the delay is documented and justified. If the inquiry finds no substance to the allegation, the matter closes at this point; the majority of allegations do not proceed past inquiry.

    Phase Two: The Investigation

    If the inquiry concludes an investigation is warranted, the process becomes formal. The respondent is notified in writing, and under federal guidance the institution must notify the Office of Research Integrity (ORI) within 30 days of that determination.

    The investigation committee, typically composed of subject-matter experts without conflicts of interest, must establish three things:

    1. Whether there was a significant departure from accepted practices in the relevant field.
    2. Whether the conduct was committed intentionally, knowingly, or recklessly.
    3. Whether the allegation is proven by a preponderance of the evidence — the standard set out in 42 C.F.R. §93.106, a lower bar than criminal “beyond reasonable doubt.”

    US institutions are expected to complete the investigation within 120 days of initiation, covering evidence review, interviews, drafting the report, and giving the respondent an opportunity to comment, per 42 C.F.R. §93.311. Extensions are routinely requested and granted where cases are complex.

    Phase Three: Adjudication

    Adjudication is the decision phase. An institutional Deciding Official — someone who played no role in the inquiry or investigation — reviews the investigation report, the respondent’s comments, and any procedural objections, then issues a final institutional finding.

    Where federal funding is involved, ORI conducts its own oversight review of the institution’s finding before any Public Health Service administrative action is imposed. According to ORI’s own published process, a respondent facing formal action retains the right to request a hearing before an Administrative Law Judge before sanctions take effect. Possible outcomes range from correction of the research record to debarment from federal funding and referral for further action.

    How Do UK and US Procedures Compare?

    The US model is unusual in having a single statutory timetable enforced through 42 C.F.R. Part 93. The UK has no equivalent statutory regulator; instead, individual institutions run their own codes of practice, informed by non-binding sector guidance.

    Feature United States (PHS-funded research) United Kingdom
    Governing instrument 42 C.F.R. Part 93 Institutional codes of practice, informed by UKRIO and UKRI guidance
    Federal/national oversight body Office of Research Integrity (ORI) None statutory; UK Research Integrity Office (UKRIO) is advisory
    Inquiry deadline 60 calendar days Not centrally mandated; varies by institution
    Investigation deadline 120 calendar days Not centrally mandated; varies by institution
    Final appeal route Hearing before an Administrative Law Judge Institutional appeal stage (naming varies, e.g. “Stage 3”)

    UKRI’s April 2025 guidance for research organisations describes an assessment stage that “refers to the process of reviewing the nature of an allegation of research misconduct” and establishing scope — functionally equivalent to the US inquiry, but without a fixed clock. UK institutional codes, such as those published by the University of Surrey and University of Staffordshire, typically layer a similar inquiry-investigation-decision logic across numbered stages, though the labelling and timeframes differ institution to institution. This is separate from journal-level handling: COPE’s flowcharts guide editors on suspected misconduct in submitted or published papers, and a publisher may pause or flag a work while the institutional process above runs in parallel.

    Answer-First Questions About Misconduct Allegations

    What are the phases of a research misconduct allegation?

    The formal process runs through three phases: an inquiry that screens whether an allegation has substance, an investigation that establishes the facts against a defined evidentiary standard, and adjudication, where a Deciding Official issues the final finding and any sanctions.

    What is the first phase in response to a research misconduct allegation?

    The first formal phase is the inquiry — a confidential, preliminary review of documents and testimony conducted to determine whether the allegation warrants a full investigation. It is not a determination of wrongdoing and, under US federal policy, must normally conclude within 60 days.

    Who investigates allegations of research misconduct?

    The employing or funded institution conducts the inquiry and investigation, typically through a Research Integrity Officer and an appointed committee of subject experts. For US federally funded research, the Office of Research Integrity then reviews the institution’s finding before any federal sanction is applied.

    What is a research misconduct allegation?

    A research misconduct allegation is a formal claim that a named individual has fabricated, falsified, or plagiarised research. It excludes honest error or genuine scientific disagreement, and it obliges the receiving institution to make a documented preliminary assessment before any formal phase begins.

    Implications and Next Steps

    For research administrators, the practical lesson is procedural discipline: documenting the preliminary assessment, meeting inquiry and investigation deadlines where they apply, and keeping the Deciding Official separate from earlier stages protects the institution against later appeal. For researchers named as respondents, understanding which phase they are in — and what standard of proof applies — clarifies what rights and evidence obligations attach at each step.

    As UK institutions continue to align local codes with UKRI’s 2025 guidance, expect greater convergence in stage naming, though a single UK statutory deadline regime, of the kind ORI enforces in the US, remains absent. Institutional research administration teams should treat the inquiry-investigation-adjudication sequence as the baseline procedural map, then check their own code of practice for the specific labels and timeframes that apply locally.